Clinically significant improvements in HbA1C and body weight loss
Journal of Digital Health • A. Khan, S. Riaz
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
March 27, 2024
International Journal of Telemedicine • F. Ahmed, R. Siddiqui
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
March 27, 2024
Journal of Digital Health • A. Khan, S. Riaz
Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial
March 27, 2024
International Journal of Telemedicine • F. Ahmed, R. Siddiqui
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
March 27, 2024
Journal of Digital Health • A. Khan, S. Riaz
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
March 27, 2024
Journal of Digital Health • A. Khan, S. Riaz
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
